LONA
LeonaBio, Inc.
NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY
$9.10
+3.76% today
Updated 2026-04-30
Market cap
$78.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.70
Dividend yield
—
52W range
$2 – $14
Volume
0.1M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$16.00
+75.82%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-19.40M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-95.64M | $-117.67M | $-96.94M | $-105.61M | $-82.89M |
| EPS | — | — | — | — | $-24.70 |
| Free cash flow | $-73.61M | $-101.06M | $-97.20M | $-45.73M | $-19.40M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
LeonaBio, Inc. trades at $9.10. Our Smart Value Score of 25/100 indicates the stock is weak.
Frequently asked questions
What is LeonaBio, Inc.'s stock price?
LeonaBio, Inc. (LONA) trades at $9.10.
Is LeonaBio, Inc. overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of LeonaBio, Inc. (LONA)?
The analyst target price is $16.00, representing +75.8% upside from the current price of $9.10.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-290.80%
Beta2.23
50D MA$8.04
200D MA$5.44
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—